The global concussion market size is expected to reach over USD 8.7 billion by 2027, expanding at a CAGR of 3.4% from forecast period 2020 to 2027.
The global concussion market size was valued at USD 6.5 billion in 2019, according to Vision Research Reports.
Increasing number of injuries being caused to the brain resulting in a high prevalence of associated disorders such as concussion is driving the market in a positive manner.
The rising number of road accidents and sports injuries, coupled with the growing vulnerable aging population, are major factors driving the market. In addition, increasing research activities on concussion diagnosis and treatment as well as the adoption of technologically advanced products are few other factors contributing to market growth.
Report Insights
Some of the prominent players in the concussion market include:
Nihon Kohden Corporation
Compumedics Ltd.
Integra Lifesciences
BioDirection, Inc.
InfraScan, Inc.
Oculogica
Raumedic AG
Market Segmentation
Assessment and Treatment Outlook
Diagnosis
Magnetic Resonance Imaging (MRI) Devices
Computed Tomography (CT) Scan
X-ray
Others
Treatment
Regional Outlook
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Concussion Market, By Assessment and Treatment
7.1. Concussion Market, By Assessment and Treatment Type, 2020-2027
7.1.1. Diagnosis
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Treatment
7.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Concussion Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.2. Europe
8.2.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.3. APAC
8.3.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.4. MEA
8.4.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.5. Latin America
8.5.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, By Assessment and Treatment (2016-2027)
Chapter 9. Company Profiles
9.1. Nihon Kohden Corporation
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Compumedics Ltd.
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Integra Lifesciences
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. BioDirection, Inc.
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. InfraScan, Inc.
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Oculogica
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Raumedic AG.
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
Glossary of Terms